Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title Expression of classical HLA class I molecules: regulation and clinical impacts: Julia Bodmer Award Review 2015
Creator René et al.
Author C. René
Author C. Lozano
Author J.-F. Eliaou
Abstract Human leukocyte antigen (HLA) class I genes are ubiquitously expressed, but in a tissue specific-manner. Their expression is primarily regulated at the transcriptional level and can be modulated both positively and negatively by different stimuli. Advances in sequencing technologies led to the identification of new regulatory variants located in the untranslated regions (UTRs), which could influence the expression. After a brief description of the mechanisms underlying the transcriptional regulation of HLA class I genes expression, we will review how the expression levels of HLA class I genes could affect biological and pathological processes. Then, we will discuss on the differential expression of HLA class I genes according to the locus, allele and UTR polymorphisms and its clinical impact. This interesting field of study led to a new dimension of HLA typing, going beyond a qualitative aspect.
Publication HLA
Volume 87
Issue 5
Pages 338-349
Date May 2016
Journal Abbr HLA
Language eng
DOI 10.1111/tan.12787
ISSN 2059-2310
Short Title Expression of classical HLA class I molecules
Library Catalog PubMed
Extra PMID: 27060357
Tags allele, Alleles, Awards and Prizes, expression, first-last-corresponding, Gene Expression Regulation, Genetic Loci, Histocompatibility Antigens Class I, Humans, major histocompatibility complex class I, Models, Biological, polymorphism, review, transplantation
Date Added 2019/05/28 - 21:45:25
Date Modified 2019/05/28 - 21:45:43
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés